Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 10, 2024 08:30 ET | Source: Palisade Bio, Inc.

Palisade Bio Cleared by Health Canada to Commence Phase 1 Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis (UC)

– Company has received a No Objection Letter from Health Canada in response to submission of its Phase 1 Clinical Trial Application (CTA) – The study is a Phase 1 Single Ascending Dose (SAD)...
April 28, 2022 11:31 ET | Source: Discovery Senior Living

Two Discovery Senior Living Team Members Appointed to Argentum's 2022 LEAD Program Cohort

BONITA SPRINGS, Fla., April 28, 2022 (GLOBE NEWSWIRE) -- Discovery Senior Living ("Discovery") has announced that team members Christian Steil and Savannah Rogers will be part of the second-ever...
March 21, 2022 07:00 ET | Source: Vallon Pharmaceuticals Inc.

Vallon Pharmaceuticals Announces Topline Results of its Pivotal SEAL Study for Lead Program, ADAIR, for the Treatment of ADHD

– Study did not meet primary endpoint of significant reduction in Emax Drug Liking for ADAIR vs reference dextroamphetamine, although a trend in favor of ADAIR was observed (p=0.16) – All...